[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
[HTML][HTML] KASL clinical practice guidelines for management of chronic hepatitis B
Korean Association for the Study of the … - Clinical and …, 2019 - ncbi.nlm.nih.gov
Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …
and the latest updates were in 2015, 2017, and 2018. However, since the medical …
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Objective High serum HBV DNA levels are associated with high risks of hepatocellular
carcinoma (HCC) and cirrhosis in patients with chronic hepatitis B (CHB). Although the …
carcinoma (HCC) and cirrhosis in patients with chronic hepatitis B (CHB). Although the …
Low‐level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
JH Kim, DH Sinn, W Kang, GY Gwak, YH Paik… - Hepatology, 2017 - journals.lww.com
The long‐term clinical impact of low‐level viremia (LLV;< 2,000 IU/mL) is not well
understood. As a result, it is unclear whether the development of LLV during entecavir …
understood. As a result, it is unclear whether the development of LLV during entecavir …
[HTML][HTML] Reversal of liver cirrhosis: current evidence and expectations
YK Jung, HJ Yim - The Korean journal of internal medicine, 2017 - ncbi.nlm.nih.gov
In the past, liver cirrhosis was considered an irreversible phenomenon. However, many
experimental data have provided evidence of the reversibility of liver fibrosis. Moreover …
experimental data have provided evidence of the reversibility of liver fibrosis. Moreover …
[HTML][HTML] Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
HJ Yim, JH Kim, JY Park, EL Yoon, H Park… - Clinical and …, 2020 - ncbi.nlm.nih.gov
Clinical practice guidelines are important for guiding the management of specific diseases
by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as …
by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as …
High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation
GH Choi, GA Kim, J Choi, S Han… - Alimentary …, 2019 - Wiley Online Library
Background It remains unknown whether antiviral treatment for HBeAg‐negative chronic
hepatitis B (CHB) patients having high viral loads without significant elevation of alanine …
hepatitis B (CHB) patients having high viral loads without significant elevation of alanine …
2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma< 3 cm: emphasis on association of local …
Objectives The purpose of this study was to evaluate the 10-year overall survival and local
tumor progression (LTP) of percutaneous radiofrequency ablation (RFA) for single nodular …
tumor progression (LTP) of percutaneous radiofrequency ablation (RFA) for single nodular …